Lapsed Nov 7, 2025 on the fee record · High confidence
20-year base term ends May 2, 2027
Second maintenance fee unpaid; grace period ended.
Held by Antares Pharma, Inc.
Filed Apr 4, 2014 as application 14/244,916 · Granted Nov 7, 2017
Base term, 20 years from filing, plus 770 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
Lapsed Nov 7, 2025
2007
2027
Clock starts
May 2, 2007
May 2, 2007
No longer in force
Nov 7, 2025
Nov 7, 2025
Granted
Nov 7, 2017
Nov 7, 2017
Term would have run to
May 2, 2027
May 2, 2027
base term
after the term ends
fee events
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
770
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 8,696,618.
1 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
7
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
Its term would have run to May 2, 2027: its 20-year base term plus 770 days of term adjustment for prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts May 2, 2007, when application PCT/US2007/067986, the earliest non-provisional in its chain, was filed (this one was filed Apr 4, 2014) | May 2, 2027 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +770 days, USPTO patent term adjustment record | Jun 10, 2029 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 8,696,618) | capped to May 2, 2027 | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 2 maintenance fees paid | lapsed Nov 7, 2025 | High confidence |
| Computed term end | The steps above, in order | Nov 7, 2025 | High confidence |
This family
| Application PCT/US2007/067986 | PCT application no patent term | no patent term |
| US 8,251,947 | In force Nov 2028 | Nov 2028 |
| US 8,696,618 | Lapsed on the fee record Apr 2026 | Apr 2026 |
| US 9,808,582 | this patent Nov 2025 | Nov 2025 |
| US 10,688,250 | In force May 2027 | May 2027 |
| US 11,547,808 | In force no later than Aug 2027 | no later than Aug 2027 |
| Application 18/064,969 | Abandoned not computed | not computed |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Mar 30, 2022 Reel 59437, frame 688 | Kramer, Thomas E.; Sadowski, Peter L. | Antares Pharma, Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Note
The 770 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Disclaimer cap
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 8,696,618.
Citations
56
later US patents cite this one
That is top 10% of utility patents granted in 2017 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.